News

Filter

1 to 9 of 21 results

Gilead's Stribild to reinforce HIV/AIDS revenues as key patents expire

06-11-2012

US biotech firm Gilead Science's (Nasdaq: GILD) combination drug Stribild (elvitegravir 150mg/cobicistat…

Anti-viralsAtriplaBiotechnologyBristol-Myers SquibbGilead SciencesMarkets & MarketingPatentsReyatazStribildSustiva

HIV market to grow 6% pa to 2013, but then slow due to generics

20-05-2009

Sales of antiretroviral agents will drive substantial 6% annual growth in the HIV drug market through…

and Tenofovir Disoproxil FumarateAtriplaBristol-Myers SquibbEfavirenzEmtricitabineEmtrivaSustiva

Teva files ANDA on Gilead

07-04-2009

US firm Gilead Sciences says it has received a Paragraph IV Certification notification advising that…

and Tenofovir Disoproxil FumarateAtriplaBristol-Myers SquibbEfavirenzEmtricitabineEmtrivaGilead SciencesGiliad SciencesSustivaTenofovir Disoproxil FumarateViread

1 to 9 of 21 results

COMPANY SPOTLIGHT

Menarini

Back to top